Nicola Silvestris

The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019

Khanh Bao Tran, Justin J. Lang, Kelly Compton et al. · The Lancet · 2022 · 886 citations · Full text

Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial

Chiara Cremolini, Carlotta Antoniotti, Daniele Rossini et al. · The Lancet Oncology · 2020 · 309 citations · Full text

Oncology, Medicine, Colorectal Cancer +8

Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study

Jinfeng Huang, Jianfei Shen, Xiao Li et al. · Annals of Translational Medicine · 2020 · 205 citations · Full text

Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine

Gianmauro Numico, Ornella Garrone, Vincenzo Dongiovanni et al. · Cancer · 2005 · 197 citations

Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells

Amalia Azzariti, Rosa Maria Iacobazzi, R. Fonte et al. · Scientific Reports · 2019 · 153 citations · Full text